| The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men (NCT00256256) | University of Aarhus | 2005-11-01 |
| Short-Term Intensive Insulin Therapy Induction of Long-term Glycemic Control (NCT00506194) | Taipei Veterans General Hospital, Taiwan | 2005-10-01 |
| Pioglitazone and Metformin in Diabetic Children (NCT01396564) | Coordinación de Investigación en Salud, Mexico | 2005-10-01 |
| Efficacy and Safety Study of MCI-196 in Patients With Type 2 Diabetes (NCT00497198) | Tanabe Pharma Corporation | 2005-10-01 |
| GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 Diabetes (NCT00300105) | AstraZeneca | 2005-10-01 |
| Measuring Cholesterol in the Fasting and Postmeal State in Patients With Type 2 Diabetes (NCT00287404) | University of North Carolina | 2005-10-01 |
| Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy. (NCT00251680) | Takeda | 2005-10-01 |
| Glycemic Durability After Metformin Failure (NCT02142309) | University of Campania Luigi Vanvitelli | 2005-10-01 |
| Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque (NCT00636766) | Aristotle University Of Thessaloniki | 2005-09-01 |
| Nurse Telephone Management of Cholesterol in Diabetes (NCT00950963) | Denver Health and Hospital Authority | 2005-09-01 |
| Using Learning Teams for Reflective Adaptation for Diabetes and Depression (NCT00414986) | University of Colorado, Denver | 2005-09-01 |
| Alberta Diabetes and Physical Activity Trial (NCT00221234) | University of Alberta | 2005-09-01 |
| G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study) (NCT00255645) | AstraZeneca | 2005-09-01 |
| A Study in Type 2 Diabetic Patients With Repeated Doses of E1 in Combination With G1 (NCT00239187) | OPKO Health, Inc. | 2005-09-01 |
| Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance (NCT00443755) | Mayo Clinic | 2005-08-01 |
| ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin Sensitivity (NCT00263965) | AstraZeneca | 2005-08-01 |
| Myocardial Perfusion in Type 2 Diabetes (NCT01043965) | University of Sao Paulo General Hospital | 2005-08-01 |
| Exercise and Activity Guidance in Older Adults With Diabetes (NCT00344240) | University of Michigan | 2005-08-01 |
| The Effects of Two Education Strategies About Insulin on Patient Preferences and Perceptions About Insulin Therapy (NCT00149331) | Hamilton Health Sciences Corporation | 2005-07-01 |
| Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 Diabetes (NCT00147745) | Daiichi Sankyo | 2005-06-01 |
| Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin (NCT00159211) | Assistance Publique - Hôpitaux de Paris | 2005-05-01 |
| Strength and Nutrition Outcomes for Latino Adolescents (NCT00697580) | University of Southern California | 2005-05-01 |
| GALLANT 22 Tesaglitazar vs. Placebo (NCT00252837) | AstraZeneca | 2005-04-01 |
| Can Insulin Glargine Improve Myocardial Function in Patients With T2D and Coronary Artery Disease (CAD) (NCT01035528) | Munich Municipal Hospital | 2005-04-01 |
| GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate (NCT00261352) | AstraZeneca | 2005-03-01 |
| Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes. (NCT00254085) | University Hospital, Gentofte, Copenhagen | 2005-03-01 |
| GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes (NCT00252876) | AstraZeneca | 2005-03-01 |
| Taking Action Together- A Diabetes Prevention Program (NCT01039116) | University of California, Berkeley | 2005-03-01 |
| Effects of Nordic Walking and Exercise on Glucose Metabolism in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (NCT01085773) | Esbjerg Hospital - University Hospital of Southern Denmark | 2005-02-01 |
| Efficacy and Safety of Cycloset® Compared With Placebo When Added to Metformin (NCT00441363) | VeroScience | 2005-02-01 |
| A Phase 1/2a Study of the 2S,4R Enantiomer of Ketoconazole in Subjects With Type 2 Diabetes Mellitus (NCT00302224) | DiObex | 2005-02-01 |
| Effect of Glargine Insulin on Glucose Control in Hospitalized Patients Who Receive Tube Feedings (NCT00177398) | University of Pittsburgh | 2005-02-01 |
| Diabetes and Metabolic Postprandial Responses (NCT00767208) | Centre de Recherche en Nutrition Humaine Rhone-Alpe | 2005-01-01 |
| Ezetimibe and Simvastatin in Dyslipidemia of Diabetes (NCT00157482) | Mario Negri Institute for Pharmacological Research | 2005-01-01 |
| Exercise and Pioglitazone for HIV-Metabolic Syndromes (NCT00639457) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2005-01-01 |
| Pioglitazone and Losartan Provides Additional Renoprotection (NCT00364988) | Shanghai Jiao Tong University School of Medicine | 2005-01-01 |
| Placebo and Active Controlled Study of Rivoglitazone in Type 2 Diabetes (NCT00143520) | Daiichi Sankyo | 2004-12-01 |
| Role of Sleep Apnea and Sympathetic Activity in Resistant Hypertensive Patients. (NCT01875341) | Ottawa Hospital Research Institute | 2004-12-01 |
| Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients With Type 2 Diabetes (NCT00151762) | Daiichi Sankyo | 2004-12-01 |
| Intensive Life-Style Intervention in Type 2 Diabetes Patients (NCT01813708) | Coordinación de Investigación en Salud, Mexico | 2004-11-01 |
| Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes (NCT00160160) | Solvay Pharmaceuticals | 2004-10-01 |
| Gene Expression Profiling and Bioinformatic Analysis Identifying Genes and Biochemical Pathways in Type 2 Diabetes (NCT00143013) | Odense University Hospital | 2004-10-01 |
| Feasibility Study of Digital Photography and Group Discussion for People With Diabetes (NCT00225888) | Joslin Diabetes Center | 2004-10-01 |
| Effect of Pioglitazone Therapy for Type 2 Diabetes on Vision (NCT00548158) | University of California, San Diego | 2004-10-01 |
| Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes (NCT00141492) | Solvay Pharmaceuticals | 2004-10-01 |
| Low Glycemic Index Diets vs. High Cereal Fibre Diets in Type 2 Diabetes (NCT00438698) | University of Toronto | 2004-09-01 |
| Combination of Sulfonylureas and Insulin Glargine Outpatient Therapy for Unstable Diabetes and Impending DKA (NCT00732524) | Cook County Health | 2004-09-01 |
| GALLANT 4 Tesaglitazar vs. Glibenclamide (NCT00255541) | AstraZeneca | 2004-09-01 |
| Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 Diabetes (NCT00202033) | HealthPartners Institute | 2004-09-01 |
| Low Carbohydrate Diet Compared to Calorie and Fat Restricted Diet in Patients With Obesity and Type II Diabetes (NCT00108459) | US Department of Veterans Affairs | 2004-09-01 |
| GALLANT 2 Tesaglitazar vs. Placebo (NCT00252772) | AstraZeneca | 2004-09-01 |
| Cardiovascular Risk Factors, Body Composition, Fitness Levels And Quality Of Life In Overweight And Obese 8-17 Year Olds (NCT02024399) | Stony Brook University | 2004-08-01 |
| Cognitive Behavioral Intervention in Diabetes Self-Management (NCT01182701) | University of Hawaii | 2004-08-01 |
| Impact of Diet and Exercise Activity on Pregnancy Outcomes (NCT00486629) | University of Manitoba | 2004-07-01 |
| Diabetes Management in Low-Income Hispanic Patients (NCT00848315) | University of Massachusetts, Worcester | 2004-07-01 |
| GALLANT 8 Tesaglitazar Add-on to Metformin (NCT00251953) | AstraZeneca | 2004-07-01 |
| Effect of Long Term α-Lipoic Acid Treatment on Endothelial Function in Patients With Type 2 Diabetes (NCT00490867) | Medical University of Vienna | 2004-07-01 |
| GALLANT 7 Tesaglitazar Add-on to Sulphonylurea (NCT00251940) | AstraZeneca | 2004-07-01 |
| Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease (NCT00513630) | Shanghai Jiao Tong University School of Medicine | 2004-06-01 |
| Low-Intermediate-Glycemic Index Caribbean Foods Versus High Glycemic Index Foods in Type 2 Diabetes (NCT00818935) | University Hospital of the West Indies | 2004-06-01 |
| WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes (NCT00147758) | Daiichi Sankyo | 2004-06-01 |
| WelChol® With Metformin in Treating Patients With Type 2 Diabetes (NCT00147719) | Daiichi Sankyo | 2004-06-01 |
| WelChol® and Insulin in Treating Patients With Type 2 Diabetes (NCT00151749) | Daiichi Sankyo | 2004-06-01 |
| A Prospective, Clinical Trial of the TANTALUS® System in Treatment of Obese to Morbidly Obese Patients (NCT00779363) | MetaCure (USA), Inc. | 2004-06-01 |
| The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of GIP (NCT02673554) | Diabeteszentrum Bad Lauterberg im Harz | 2004-05-01 |
| Exercise Training in Type 2 Diabetes and Hypertension (NCT00212303) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2004-05-01 |
| Dose Response Study in Japanese Patients (NCT00261417) | AstraZeneca | 2004-05-01 |
| Lifestyle Interventions for Long Term Diabetes Control (NCT00364312) | University of Virginia | 2004-05-01 |
| Longitudinal Cohort Study Comparing 2 Surgical Techniques in Patients With Class 3 Obesity and Type 2 Diabetes (NCT00688974) | University Hospital, Lille | 2004-05-01 |
| Diabetes Dietary Study- Low Carbohydrate and Low-Fat Diets in Type 2 Diabetes (NCT00795691) | Albert Einstein College of Medicine | 2004-05-01 |
| Treatment of Patients With Type 2 Diabetes With an Interleukin-1 Antagonist (NCT00303394) | University of Zurich | 2004-04-01 |
| Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes (NCT00609856) | Skane University Hospital | 2004-04-01 |
| Effects on NF-κB Activity: High Dose Simvastatin Versus Combination Therapy With Ezetimibe (NCT01424891) | Heidelberg University | 2004-04-01 |
| Effect of High Monounsaturated Fat Diet on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes (NCT00622960) | University of Cincinnati | 2004-04-01 |
| Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 Diabetes (NCT00738023) | Emory University | 2004-03-01 |
| Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes (NCT00419484) | Dokkyo Medical University | 2004-03-01 |
| Change of Lifestyle by Persons in Risk of Type 2 Diabetes (NCT00202748) | Sorlandet Hospital HF | 2004-03-01 |
| Mediterranean Diet and Postprandial Lipemia (NCT00789295) | Federico II University | 2004-03-01 |
| Mechanism of Insulin-Resistant in Lean Non-Diabetics (NCT00970099) | University of California, San Francisco | 2004-02-01 |
| Medical Nutrition Therapy Program for Pregnant Women With Diabetes (NCT00860613) | Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes | 2004-02-01 |
| Dietary Fish Protein in Subjects With Insulin Resistance (NCT00400036) | Laval University | 2004-02-01 |
| Flexible, Intensive vs. Conventional Insulin Therapy in Insulin-Naive Adults With Type 2 Diabetes (NCT00440284) | University of Jena | 2004-01-01 |
| Actos Now for Prevention of Diabetes (ACT NOW) (NCT00220961) | The University of Texas Health Science Center at San Antonio | 2004-01-01 |
| n-3 Fatty Acid Infusion and Type 2 Diabetes (NCT00829569) | St. Olavs Hospital | 2004-01-01 |
| Effect of Angiotensin Receptor Blockade on Insulin Resistance and Adipose Tissue Cytokines in Type 2 Diabetes (NCT01011062) | Institute for Clinical and Experimental Medicine | 2004-01-01 |
| Therapeutic Effects of Berberine in Patients With Type 2 Diabetes (NCT00425009) | Shanghai Jiao Tong University School of Medicine | 2004-01-01 |
| Effect of GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Subjects With Type 2 Diabetes (NCT00451620) | University of British Columbia | 2003-11-01 |
| Effect of Chromium Picolinate on Insulin Sensitivity in Type 2 Diabetes (NCT00398853) | Pennington Biomedical Research Center | 2003-10-01 |
| Telemedicine Influence in the Follow up of the Type 2 Diabetes Patient (NCT00527254) | Province of Malaga Health Department | 2003-10-01 |
| A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics (NCT00240370) | Bristol-Myers Squibb | 2003-10-01 |
| Prospective Study of Patients With Hirsutism (NCT00145288) | Odense University Hospital | 2003-10-01 |
| Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With Pioglitazone (NCT00737347) | Northwestern University | 2003-09-01 |
| Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria (NCT00320879) | Steno Diabetes Center Copenhagen | 2003-09-01 |
| Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes (NCT00191178) | Eli Lilly and Company | 2003-08-01 |
| Effect of Arginine on Microcirculation in Patients With Diabetes (NCT00902616) | Tameside Hospital NHS Foundation Trust | 2003-06-01 |
| 24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine (NCT00551538) | Eli Lilly and Company | 2003-05-01 |
| Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine) (NCT00653302) | Sanofi | 2003-04-01 |
| Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early Nephropathy (NCT00157508) | Mario Negri Institute for Pharmacological Research | 2003-03-01 |
| The Effects of Anti-Inflammatory Treatment on Insulin Resistance in Healthy Volunteers (NCT00339833) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2003-03-01 |
| GIP: Glucose-dependent Insulinotropic Peptide (NCT00239707) | National Institute on Aging (NIA) | 2003-02-01 |